Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
---|---|---|---|---|---|---|---|---|---|
FBRX | Forte Biosciences, Inc. | Common Stock, $0.001 par value | 6.76% | $2.59M | 432K | Nemean Asset Management, LLC | Nov 20, 2024 | ||
ATHA | Athira Pharma, Inc. | Common Stock | 5.11% | $638K | 1.99M | Steven Michael Oliveira | Apr 14, 2025 |
Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
---|